<DOC>
	<DOCNO>NCT00003643</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know regimen combination chemotherapy may effective germ cell cancer . PURPOSE : This randomized phase II/III trial study two different regimen combination chemotherapy compare well work treat men germ cell cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Men With Germ Cell Cancer</brief_title>
	<detailed_description>OBJECTIVES : Phase II - Compare complete response rate men intermediate prognosis germ cell cancer treat bleomycin , cisplatin , etoposide ( BEP ) v bleomycin , cisplatin , etoposide , paclitaxel ( T-BEP ) . - Define toxicity profile T-BEP patient . Phase III - Compare disease-free survival patient treat regimen . - Compare complete response rate overall survival patient treat regimen . - Compare symptom aspects quality life baseline treatment patient treat regimen . - Compare acute intermediate ( 1-2 year ) side effect regimens patient . OUTLINE : This randomize , multicenter study . Patients stratify accord histology ( seminoma v non-seminoma ) hospital . Patients randomize 1 2 treatment arm . - Arm I : Patients receive cisplatin IV etoposide IV day 1-5 bleomycin IV day 1 , 8 , 15 . - Arm II : Patients receive cisplatin , etoposide , bleomycin arm I paclitaxel IV 3 hour day 1 . Patients also receive filgrastim ( G-CSF ) subcutaneously day 6-15 . In arm , treatment repeat every 3 week total 4 course absence disease progression unacceptable toxicity . Quality life assess treatment randomization 1 2 year randomization . Patients follow monthly 1 year , every 2 month 1 year , every 3 month 1 year , every 6 month 1 year , annually thereafter . PROJECTED ACCRUAL : A total 84-164 patient ( 42-82 per treatment arm ) accrue phase II study . A total 498 patient ( 249 per treatment arm ) accrue phase III study . Accrual complete within 4 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Teratoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven germ cell cancer Seminoma Nonseminoma Combined Intermediate prognosis Nonseminoma : Testis/retroperitoneal primary No nonpulmonary visceral metastasis Meets 1 follow criterion : Alphafetoprotein ( AFP ) 1,000 10,000 IU/L Human chorionic gonadotropin ( hCG ) 5,00050,000 IU/L Lactic dehydrogenase ( LDH ) 1.5 times10 time upper limit normal ( ULN ) Seminoma : Any primary site Any LDH HCG AFP normal Nonpulmonary visceral metastasis present PATIENT CHARACTERISTICS : Age : 16 50 Sex : Male Performance status : WHO 02 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.25 time ULN AST great 2 time ULN Renal : Creatinine clearance least 40 mL/min ( unless due obstructive uropathy relieve nephrostomy ) Other : No preexist neuropathy No malignancy except basal cell skin cancer No serious illness medical condition incompatible protocol PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>Male</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>testicular seminoma</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor seminoma</keyword>
	<keyword>testicular embryonal carcinoma seminoma</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular yolk sac tumor teratoma seminoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
	<keyword>testicular choriocarcinoma seminoma</keyword>
	<keyword>stage IV extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage IV extragonadal seminoma</keyword>
	<keyword>testicular immature teratoma</keyword>
	<keyword>testicular mature teratoma</keyword>
	<keyword>adult teratoma</keyword>
</DOC>